Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Platform: GPL24247 | Hongjian Jin | ||||||
GSE218274 |
PAX3-FOXO1 expression in endothelial progenitors dictates myogenic reprogramming and rhabdomyosarcoma identity
|
75 | Hongjian Jin | Sep 29, 2023 | ||||
GSE218265 |
PAX3-FOXO1 expression in endothelial progenitors dictates myogenic reprogramming and rhabdomyosarcoma identity[Cut&Run]
|
15 | Hongjian Jin | Sep 30, 2023 | ||||
GSE166906 |
Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity
|
29 | Hongjian Jin | Aug 24, 2021 | ||||
GSE218254 |
PAX3-FOXO1 expression in endothelial progenitors dictates myogenic reprogramming and rhabdomyosarcoma identity[Hi-C]
|
4 | Hongjian Jin | Sep 30, 2023 | ||||
GSE240506 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
|
26 | Hongjian Jin | Mar 02, 2024 | ||||
GSE240505 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma [RNA-seq]
|
22 | Hongjian Jin | Mar 04, 2024 | ||||
GSE240980 |
Cellular fitness of MYC-driven cancer cells to genetic and pharmacologic perturbations in normoxia, hypoxia and 3D
|
8 | Hongjian Jin | Jun 26, 2024 | ||||
GSE218358 |
PAX3-FOXO1 drives tumor formation from multiple lineages [scRNA-seq]
|
13 | Hongjian Jin | Sep 30, 2023 | ||||
GSE166808 |
Quantitative assessment of transcriptomic differences between ASPcKO and ASPcKOP7cKO flow cytometry-sorted murine FN-RMSs by RNA sequencing
|
8 | Hongjian Jin | Aug 24, 2021 | ||||
GSE172221 |
A genetic mouse model of malignant peripheral nerve sheath tumor with postnatal Nf1 and p53 loss recapitulates the histology and transcriptome of human tumors
|
44 | Hongjian Jin | Mar 24, 2024 | ||||
GSE193124 |
Genome-wide mapping of oncogenic pathways and genetic modifiers of chemotherapy using a high-risk hepatoblastoma genetic model
|
6 | Hongjian Jin | Jun 22, 2023 | ||||
GSE218357 |
PAX3-FOXO1 drives tumor formation from multiple lineages [RNA-seq]
|
31 | Hongjian Jin | Sep 30, 2023 |